Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain.
Blood. 2013 Jul 4;122(1):44-54. doi: 10.1182/blood-2012-12-472845. Epub 2013 May 15.
Hematopoietic stem cells self-renew for life to guarantee the continuous supply of all blood cell lineages. Here we show that Poly(ADP-ribose) polymerase-2 (Parp-2) plays an essential role in hematopoietic stem/progenitor cells (HSPC) survival under steady-state conditions and in response to stress. Increased levels of cell death were observed in HSPC from untreated Parp-2-/- mice, but this deficit was compensated by increased rates of self-renewal, associated with impaired reconstitution of hematopoiesis upon serial bone marrow transplantation. Cell death after γ-irradiation correlated with an impaired capacity to repair DNA damage in the absence of Parp-2. Upon exposure to sublethal doses of γ-irradiation, Parp-2-/- mice exhibited bone marrow failure that correlated with reduced long-term repopulation potential of irradiated Parp-2-/- HSPC under competitive conditions. In line with a protective role of Parp-2 against irradiation-induced apoptosis, loss of p53 or the pro-apoptotic BH3-only protein Puma restored survival of irradiated Parp-2-/- mice, whereas loss of Noxa had no such effect. Our results show that Parp-2 plays essential roles in the surveillance of genome integrity of HSPC by orchestrating DNA repair and restraining p53-induced and Puma-mediated apoptosis. The data may affect the design of drugs targeting Parp proteins and the improvement of radiotherapy-based therapeutic strategies.
造血干细胞自我更新以保证所有血细胞谱系的持续供应。在这里,我们表明聚(ADP-核糖)聚合酶-2(Parp-2)在稳态条件下和应激反应中对造血干/祖细胞(HSPC)的存活起着至关重要的作用。未处理的 Parp-2-/- 小鼠的 HSPC 中观察到细胞死亡水平增加,但这种缺陷通过自我更新率的增加得到了补偿,这与骨髓移植后造血重建受损有关。γ 辐射后细胞死亡与缺乏 Parp-2 时 DNA 损伤修复能力受损有关。在亚致死剂量的 γ 辐射暴露下,Parp-2-/- 小鼠表现出骨髓衰竭,这与竞争条件下辐照 Parp-2-/- HSPC 的长期再群体潜力降低有关。与 Parp-2 对辐射诱导细胞凋亡的保护作用一致,p53 或促凋亡 BH3 仅蛋白 Puma 的缺失恢复了辐照 Parp-2-/- 小鼠的存活,而 Noxa 的缺失则没有这种作用。我们的研究结果表明,Parp-2 通过协调 DNA 修复和抑制 p53 诱导的和 Puma 介导的细胞凋亡,在 HSPC 基因组完整性的监测中起着至关重要的作用。这些数据可能会影响针对 Parp 蛋白的药物设计和基于放疗的治疗策略的改进。